Walk into any pharmacy and the probiotic section will overwhelm you with billion CFU counts, colorful packaging, and vague claims about digestive health. Most people grab whatever looks most impressive and assume more is better.
But a 2023 randomized clinical trial put two of the most studied probiotic strains head to head in patients with irritable bowel syndrome — and what it found exposes a fundamental misunderstanding about how probiotics actually work.
One strain reduced the frequency and intensity of abdominal pain. The other improved bowel regularity and satisfaction. Same diagnosis. Same study. Same duration. Completely different outcomes depending on which strain patients received.
The CFU count on the label had nothing to do with it.
What determined the outcome was the specific strain — because different probiotic strains colonize different parts of the gut, produce different compounds, interact with different immune pathways, and generate completely different effects in the body. Choosing a probiotic without knowing what specific strains it contains is like choosing a medication without knowing what it treats.
This is why strain specificity matters more than any other factor in probiotic selection — and why the research community has moved decisively away from generic probiotic recommendations toward studying individual strains and their precise mechanisms.
Bacillus coagulans — one of the strains highlighted in that 2023 trial — has been studied extensively for digestive comfort, immune modulation, and gut-brain communication. Bacillus subtilis has been studied for its immune-strengthening effects on mucosal defense and its extraordinary ability to survive the harsh environment of the digestive tract in spore form.
Together they address different systems through different mechanisms — which is exactly the point.
Longevity contains 1 billion CFUs each of Bacillus coagulans and Bacillus subtilis — two clinically studied spore-forming strains chosen for their specific and complementary effects on gut health, immune function, and the gut-brain axis as part of a complete daily nutritional routine.
Because with probiotics, what matters isn't just how much you take. It's what you're actually taking.
References
Majeed M, et al. (2023). "Comparative clinical evaluation of Bacillus coagulans and Bifidobacterium lactis in irritable bowel syndrome." Journal of Clinical Medicine. Available via PubMed.